ClinicalTrials.gg
Not yet recruitingNCT07085403Updated Aug 13, 2025

Let's CO-OPerate! Together we Are Stronger

An interventional study of Cognitive Orientation to daily Occupational Performance (CO-OP) is a cognitive problem-solving approach in Executive Function Deficits (EFD), Developmental Coordination Disorder and Acquired Brain Injury (Including Stroke), sponsored by Hopitaux de Saint-Maurice. Not yet recruiting at 1 site in France. Open to participants aged 8 Years to 16 Years. Per ClinicalTrials.gov, last updated 2025-08-13.

Sponsored by Hopitaux de Saint-Maurice · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
8 Years to 16 Years
Sex
All
01

Study summary

The goal of this replicated single case experimental study using a randomized multiple baseline design across participants and goals is to enable children/adolescents (aged 8-16 years) with developmental coordination disorders and/or executive function deficits following an acquired or congenital brain injury, to achieve their occupational goals. The aim is to make them more independents and autonomous in their daily lives. To achieve this, we're going to offer them an intensive group CO-OP (Cognitive Orientation to daily Occupational Performance Approach) rehabilitation training, and actively involving the parents. The main questions it aims to answer are:

  • To evaluate the improvement in occupational performance* (and its maintenance over time) following intervention using the CO-OP Approach.

    *Occupational performance is a person's ability to choose, organize and engage in meaningful occupations that give them satisfaction. These occupations, determined by culture and corresponding to their age group, enable them to take care of themselves, have fun and contribute to the social and economic fabric of the community.

  • To gather parents' experiences of supporting their child during the CO-OP intervention and its follow-up phase.

Participants will be asked to identify 3 goals that they would like to achieve with the CO-OP Approach. The CO-OP intervention will take the form of two half-days a week for 5 weeks, with 1 hour 30 minutes of individual CO-OP sessions and 1 hour 30 minutes of group sessions.

02

Conditions studied

  • Executive Function Deficits (EFD)
  • Developmental Coordination Disorder
  • Acquired Brain Injury (Including Stroke)
  • Brain Injury, Fetus and Neonate

Keywords

  • paediatric rehabilitation
  • occupational therapy
  • executive function deficits
  • developmental coordination disorder
  • acquired brain injury
  • fetus and neonate brain injury
  • Cognitive Orientation to daily Occupational Performance (CO--OP)
  • intensive training
  • individual and group rehabilitation
03

In context

Motor Skills Disorders

105 studies on the registry are indexed under Motor Skills Disorders; 29 are open to participants now.

This study's planned enrollment of 12 is below the median of 40 across 76 interventional studies indexed under Motor Skills Disorders.

Browse Motor Skills Disorders studies →

Lead sponsor

Hopitaux de Saint-Maurice is the lead sponsor of 16 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion criteria:

  • Children/adolescents (8-16 years old) with coordination disorders and/or executive function deficits, following a acquired brain injury more than 3 months ago or a congenital brain lesion or a neurodevelopmental disorder.
  • Executive function deficits as assessed by neuropsychological tests (standardised tests and/or questionnaires) and/or coordination disorders as assessed by neuropsychological tests (standardised tests and/or questionnaires).
  • Vision and hearing normal or sufficient to communicate effectively (with appropriate correction where necessary).
  • Cognitive, behavioural and expressive/receptive communication skills enabling them to identify goals and participate actively in the CO-OP intervention process.
  • Membership of a health insurance scheme or beneficiary.
  • Agreement of the child/adolescent and expressed by at least one of the holders of parental authority.

Non-inclusion criteria :

  • Children/adolescents who do not meet the inclusion criteria.
  • Children/adolescents and/or parents non-French-speaking.
  • Presenting intellectual difficulties, or severe problems of comprehension, memory or attention, as described in the CO-OP recommendations.
  • A diagnosed severe anxiety-depressive disorder that is not compatible with participation in the study.
  • Inability to remain involved until the end of the CO-OP intervention phase (e.g. planned move).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    COOP experimental arm

    Other: Cognitive Orientation to daily Occupational Performance (CO-OP) is a cognitive problem-solving approach

Interventions

  • OtherCognitive Orientation to daily Occupational Performance (CO-OP) is a cognitive problem-solving approach

    Cognitive Orientation to daily Occupational Performance (CO-OP; CO-OP approach) is a performance-based treatment approach for children and adults who experience difficulties performing the skills they want to, need, to or are expected to perform. CO-OP is a specifically tailored, active client-centered approach that engages the individual at the meta-cognitive level to solve performance problems. Focused on enabling success, the CO-OP approach employs collaborative goal setting, dynamic performance analysis, cognitive strategy use, guided discovery, and enabling principles. These elements, all considered essential to the CO-OP Approach, are situated within a structured intervention format, and may involve the parent/significant other as appropriate.

06

What researchers measure

Primary outcomes

  1. Goal Attainment Scale (GAS)

    The Goal Attainment Scale (GAS) is a criterion--referenced measure used to quantify the degree to which personal goals are achieved. GAS methodology consists in: * Defining a rehabilitation goal; * Choosing an observable behaviour that reflects the degree of goal attainment; * Defining the patient's initial level with respect to the goal; * Ranging from a ''no change'' to a ''much better than expected outcome''); * Evaluating the patient after a defined time interval; * Calculating the overall attainment score for all the rehabilitation goals. A five-point scale will be used: "-2" is the initial pretreatment level; "-1" represents progression towards the goal without goal attainment; ''0'' is the expected level after treatment, (and therefore, the ''most likely'' level after treatment); ''+1'' represents a better outcome than expected; ''+2'' is the best possible outcome that could have been expected for this goal.

    Time frame: Baseline to 6-months post-intervention: two times per week during baseline and intervention phase for each chosen-goal ; one time at 2, 4 and 6-months post-intervention.

Secondary outcomes

  1. Canadian Occupational Performance Measure (COPM)

    The Canadian Occupational Performance Measure is an individualized, client--centered, semi--structured interview used to identify occupational performance issues.For each performance issue, perceived performance and satisfaction are scored on a 1 to 10 Likert scale. Performance and satisfaction are rated by children and parents on a scale of 1 to 10 (1= not at all able to perform the activity (performance) / not at all satisfied with the way the activity is performed (satisfaction); 10 = perfectly able to perform the activity (performance) / perfectly satisfied with the way the activity is performed (satisfaction). A difference of 2 points between pre- and post-intervention is clinically significant. For each self--identified goal, four different COPM ratings will be obtained: (1) the participant's perceived occupational performance rating; (2) the participant's satisfaction rating; (3) the parent's perceived occupational performance rating; (4) the parent's satisfaction rating.

    Time frame: Once before baseline, at immediate post-intervention, at 2, 4 and 6-months post-intervention.

  2. Behavior Rating Inventory of Executive Function questionnaire (BRIEF)

    The Behavior Rating Inventory of Executive Function questionnaire (BRIEF, or BRIEF-A for adults'version) provide an ecological assessment of executive functioning through its repercussions in family and school context. Currently, this questionnaire is the best validated and most widely used in children in various congenital, developmental or acquired conditions. The outcome measure is the Global Executive Composite score (GEC) T-Scores (Mean: 50; SD: 10; clinical range cutoff: T-Scores≥65).

    Time frame: twice in baseline, once in immediate post-intervention and once at 2,4,6 month post-intervention.

  3. Entretien Engagement des Proches

    The aim of this interview is to collect information on the experience of use of CO-OP by family caregivers with the participant, outside of rehabilitation sessions. No scale of score, the interviews will be analyzed according to a qualitative description.

    Time frame: once at immediate post-intervention, 4 and 6 months-post-intervention]

Other outcomes

  1. Behavioural Assessment of the Dysexecutive Syndrome for Children (BADS-C) (aged 8-- 15 years)

    Behavioural Assessment of the Dysexecutive Syndrome for Children (BADS-C) predicts everyday problems associated with a major area of cognitive deficit that can impede functional recovery and the ability to respond to rehabilitation programs. The therapist can be use 2 subtests to assess the executive functions deficits (Zoo Part 1 and 2 subtest; Six parts subtest). Standard scores: mean 10 (SD: 3).

    Time frame: Once before the baseline for children aged 8-15 years

  2. Behavioural Assessment of the Dysexecutive Syndrome (BADS) (participants aged 16 years)

    Behavioural Assessment of the Dysexecutive Syndrome (BADS) predicts everyday problems associated with a major area of cognitive deficit that can impede functional recovery and the ability to respond to rehabilitation programs. The therapist can be use 2 subtests to assess the executive functions deficits (Zoo Part 1 and 2 subtest; Six elements subtest). Standard scores : means 10 (SD: 3).

    Time frame: Once before the baseline for participants aged 16 years

  3. Movement Assessment Battery for Children (M-ABC)

    The M-ABC is designed to identify and describe impairments in motor performance of children and adolescents. It will be use to assess developmental coordination disorders. Standard scores: mean 10 (3).

    Time frame: once before the baseline

  4. Wechsler Intelligence Scale for Children (WISC)

    Wechsler Intelligence Scale for Children is an intelligence test that measures a child's intellectual ability and 5 cognitive domains that impact performance. This test (or equivalent, depending on the neuropsychologist's decision) will be used to assess development coordination disorders and/or executive function deficits. Standard scores for index: mean 100 (SD: 15); Standard scores for subtests: mean 10 (SD: 3).

    Time frame: once before the baseline

  5. Children Cooking Test (CCT)

    The Children's Cooking Task (CCT) is a complex test that has been specifically developed to assess executive functions in a standardized open-ended environment (cooking). The CCT can be used by therapists to assess executive function deficits. Number of errors / z score (compared to age-matched controls); Task duration (min) / z score (compared to age-matched controls).

    Time frame: once before the baseline

07

Study locations

1 site
08

References and documents

Publications

  • Steenbeek D, Ketelaar M, Galama K, Gorter JW. Goal Attainment Scaling in paediatric rehabilitation: a report on the clinical training of an interdisciplinary team. Child Care Health Dev. 2008 Jul;34(4):521-9. doi: 10.1111/j.1365-2214.2008.00841.x. PubMed 19154553 ↗
  • Polatajko HJ, Mandich AD, Missiuna C, Miller LT, Macnab JJ, Malloy-Miller T, Kinsella EA. Cognitive orientation to daily occupational performance (CO-OP): part III--the protocol in brief. Phys Occup Ther Pediatr. 2001;20(2-3):107-23. PubMed 11345506 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2025; primary completion for May 2027, 20 months later.

Of 46 non-industry interventional studies with no phase under Motor Skills Disorders, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 50. This study's planned 20 months is above that.

Counting every sponsor, half of 46 studies reached it within 17 months; a quarter within 8 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 4, 2025
First posted
Jul 25, 2025
StartEst.
Sep 1, 2025
Primary completionEst.
May 1, 2027
CompletionEst.
May 1, 2027
Last update
Aug 13, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07085403
Lead sponsor
Hopitaux de Saint-Maurice
Responsible party
Hélène LEBRAULT (principal investigator, Hopitaux de Saint-Maurice) — Principal investigator
First posted
Jul 25, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
May 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Aug 13, 2025

Study contacts

Helene LEBRAULT, OT, PhD
Contact
helene.lebrault@ght94n.fr
+0033143966682

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion